MyBlueDotsOncology & CancerLung cancer trial reveals 40% drop in deaths using biomarker testing MyBlueDots3 months ago01 mins New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths. Go to Source Author: Post navigation Previous: Data-driven study reveals falling use of antiseizure drug in pregnancyNext: AI analysis reveals four long COVID patient subgroups and needs
Age-related genetic changes in the blood associated with poor cancer prognosis MyBlueDots2 days ago 0
TRIM63 identified as key gene in common heart disease, unlocking potential for earlier diagnosis MyBlueDots2 days ago 0
Newly discovered cells in connective tissue open up strategy against pancreatic cancer MyBlueDots2 days ago 0